Xichao Ou

1.7k total citations · 1 hit paper
55 papers, 1.2k citations indexed

About

Xichao Ou is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Xichao Ou has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 50 papers in Infectious Diseases and 19 papers in Surgery. Recurrent topics in Xichao Ou's work include Tuberculosis Research and Epidemiology (50 papers), Mycobacterium research and diagnosis (48 papers) and Diagnosis and treatment of tuberculosis (10 papers). Xichao Ou is often cited by papers focused on Tuberculosis Research and Epidemiology (50 papers), Mycobacterium research and diagnosis (48 papers) and Diagnosis and treatment of tuberculosis (10 papers). Xichao Ou collaborates with scholars based in China, United States and Netherlands. Xichao Ou's co-authors include Yanlin Zhao, Hui Xia, Shengfen Wang, Bing Zhao, Yuanyuan Song, Yang Zhou, Qiang Li, Daniel P. Chin, Yu Pang and Guangxue He and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xichao Ou

46 papers receiving 1.1k citations

Hit Papers

National Survey of Drug-Resistant Tuberculosis in China 2012 2026 2016 2021 2012 100 200 300 400

Peers

Xichao Ou
Yu Pang China
Chris Gilpin Australia
Kenneth Jost United States
André Trollip South Africa
Louis Grandjean United Kingdom
Xichao Ou
Citations per year, relative to Xichao Ou Xichao Ou (= 1×) peers Guanglu Jiang

Countries citing papers authored by Xichao Ou

Since Specialization
Citations

This map shows the geographic impact of Xichao Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xichao Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xichao Ou more than expected).

Fields of papers citing papers by Xichao Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xichao Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xichao Ou. The network helps show where Xichao Ou may publish in the future.

Co-authorship network of co-authors of Xichao Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Xichao Ou. A scholar is included among the top collaborators of Xichao Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xichao Ou. Xichao Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Wei, Xichao Ou, Bing Zhao, et al.. (2025). High-Level Primary Pretomanid-Resistant with ddn In-Frame Deletion of Mycobacterium tuberculosis and Its Association with Lineage 4.5 in China. ACS Omega. 10(25). 26551–26559. 1 indexed citations
2.
Han, Zhiqiang, Xichao Ou, Ruiqing Zhang, et al.. (2025). A duplex one-step recombinase aided PCR assay for the rapid and sensitive detection of the isoniazid resistance genes katG and inhA in Mycobacterium tuberculosis. Frontiers in Microbiology. 16. 1548965–1548965.
3.
Liu, Dongxin, Bing Zhao, Zheng Yang, et al.. (2024). Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China. SHILAP Revista de lepidopterología. 3(3). 100129–100129. 4 indexed citations
4.
Ou, Xichao, Bing Zhao, Qian Sun, et al.. (2024). Development and preliminary assessment of the iFIND TBR: all-in- one molecular diagnostic assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance. Frontiers in Cellular and Infection Microbiology. 14. 1439099–1439099.
5.
He, Wencong, Yun‐Hong Tan, Binbin Liu, et al.. (2024). Transmission dynamics of tuberculosis in a high-burden area of China: An 8-year population-based study using whole genome sequencing. International Journal of Infectious Diseases. 147. 107210–107210. 1 indexed citations
6.
Zhao, Bing, Huiwen Zheng, Juliano Timm, et al.. (2024). Prevalence and genetic basis of Mycobacterium tuberculosis resistance to pretomanid in China. Annals of Clinical Microbiology and Antimicrobials. 23(1). 40–40. 2 indexed citations
7.
Ou, Xichao, et al.. (2024). Phylogenetically Informative Mutations in Drug Resistance Genes of Human‐Infecting Mycobacterium bovis. Transboundary and Emerging Diseases. 2024(1). 5578214–5578214. 1 indexed citations
8.
Zheng, Huiwen, Yi‐Ting Wang, Wencong He, et al.. (2023). Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China. Microbial Drug Resistance. 29(3). 112–114.
9.
Xia, Hui, Yuanyuan Song, Zheng Yang, et al.. (2022). Detection of Mycobacterium tuberculosis Rifampicin Resistance Conferred by Borderline rpoB Mutations: Xpert MTB/RIF is Superior to Phenotypic Drug Susceptibility Testing. Dove Medical Press (Taylor and Francis Group). 12 indexed citations
10.
Feng, Yuqing, Xichao Ou, Chunfa Liu, et al.. (2022). Genomic analysis of diversity, biogeography, and drug resistance in Mycobacterium bovis. Transboundary and Emerging Diseases. 69(5). e2769–e2778. 5 indexed citations
11.
Li, Hui, Chunfa Liu, Minghui Liang, et al.. (2021). Tuberculosis Outbreak in an Educational Institution in Henan Province, China. Frontiers in Public Health. 9. 737488–737488. 9 indexed citations
12.
Ou, Xichao, Hui Xia, Shengfen Wang, et al.. (2021). National Proficiency Testing of Molecular Diagnostics for Tuberculosis and Drug Resistance Detection — China, 2014–2019. China CDC Weekly. 3(12). 247–251.
13.
Zhou, Yang, Richard Anthony, Shengfen Wang, et al.. (2020). The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives. Journal of Infection. 80(4). 444–453. 14 indexed citations
15.
Ou, Xichao, Shengfen Wang, Haiyan Dong, et al.. (2016). Multicenter evaluation of a real-time loop-mediated isothermal amplification (RealAmp) test for rapid diagnosis of Mycobacterium tuberculosis. Journal of Microbiological Methods. 129. 39–43. 11 indexed citations
16.
Pang, Yu, Yang Zhou, Shengfen Wang, et al.. (2015). Prevalence and risk factors of mixed Mycobacterium tuberculosis complex infections in China. Journal of Infection. 71(2). 231–237. 19 indexed citations
17.
Hu, Peilei, Liqiong Bai, Xichao Ou, et al.. (2014). Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China. Chinese Medical Journal. 127(21). 3744–3750. 8 indexed citations
18.
Ou, Xichao, Yuanyuan Song, Bing Zhao, et al.. (2014). A multicenter study of Cross-Priming Amplification for tuberculosis diagnosis at peripheral level in China. Tuberculosis. 94(4). 428–433. 23 indexed citations
19.
Ou, Xichao, Hui Xia, Qiang Li, et al.. (2014). A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China. International Journal of Infectious Diseases. 31. 41–46. 20 indexed citations
20.
Ou, Xichao, Qiang Li, Hui Xia, et al.. (2014). Diagnostic Accuracy of the PURE-LAMP Test for Pulmonary Tuberculosis at the County-Level Laboratory in China. PLoS ONE. 9(5). e94544–e94544. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026